Carcinogenesis, Vol. 21, No. 10, 1777-1787,
October 2000
© 2000 Oxford University Press
Accelerated Paper |
Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging
Center for Glomerulonephritis, Renal Division, Emory University and the VAMC, Atlanta, GA 30322,
1 Department of Pathology, Emory University, Atlanta, GA and
2 Laboratory of Molecular Carcinogenesis, NIEHS, Research Triangle Park, NC, USA
We recently reported that the mutant form of the tumor-suppressor gene p53 up-regulates 15-LO-1 gene expression in a murine cell line. Here, we examine the expression of 15-lipoxygenase (LO)-1 and mutant p53 (mtp53) in human prostatic tissues and 15-LO-1 in the human prostate adenocarcinoma cell line PC-3. Reverse transcription–PCR and western analyses conclusively demonstrated expression of 15-LO-1 in PC-3 cells. Western blotting for 15-LO-1 in freshly resected `normal' and prostate adenocarcinoma specimens showed 15-LO-1 expression in normal tissue, but significantly higher levels were detected in prostate adenocarcinomas. Prostate adenocarcinoma tissues generated chirally pure 13-S-hydroxyoctadecadienoic acid from exogenous linoleic acid, a preferred substrate of 15-LO-1. To study the correlation of 15-LO-1 expression with mtp53 in prostate cancer, we immunostained 48 prostatectomy specimens obtained by transurethral resection of the prostate and needle biopsy (median age 68 years, range 52–93) of different Gleason grades (n = 48), using antibodies specific for 15-LO-1, mtp53 and MIB-1 (a proliferation marker). We compared staining in cancerous foci with adjacent normal appearing prostate tissues. In only 5 of 48 patients did `normal' tissue adjacent to cancerous foci display staining for 15-LO-1. However, no staining for mtp53 was observed in any of the normal tissues. In cancer foci, robust staining was observed for both 15-LO-1 (36 of 48, 75%) and mtp53 (19 of 48, 39%). Furthermore, the intensities of expression of 15-LO-1 and mtp53 correlated positively with each other (P < 0.001) and with the degree of malignancy, as assessed by Gleason grading (P < 0.01). By immunohistochemistry, 15-LO-1 was located in secretory cells of peripheral zone glands, prostatic ducts and seminal vesicles, but not in the basal cell layer or stroma. Based on these and other studies, we propose a model describing a possible role for 15-LO-1 expression in influencing the malignant potential and pathobiological behavior of adenocarcinomas.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Voloshyna, A. Besana, M. Castillo, T. Matos, I. B. Weinstein, M. Mansukhani, R. B. Robinson, C. Cordon-Cardo, and S. J. Feinmark TREK-1 Is a Novel Molecular Target in Prostate Cancer Cancer Res., February 15, 2008; 68(4): 1197 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chouinard, G. Pelletier, A. Belanger, and O. Barbier Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation Endocrinology, November 1, 2006; 147(11): 5431 - 5442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Torosyan, A. Dobi, S. Naga, K. Mezhevaya, M. Glasman, C. Norris, G. Jiang, G. Mueller, H. Pollard, and M. Srivastava Distinct Effects of Annexin A7 and p53 on Arachidonate Lipoxygenation in Prostate Cancer Cells Involve 5-Lipoxygenase Transcription Cancer Res., October 1, 2006; 66(19): 9609 - 9616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Tassabehji, J. W. VanLandingham, and C. W. Levenson Copper Alters the Conformation and Transcriptional Activity of the Tumor Suppressor Protein p53 in Human Hep G2 Cells Experimental Biology and Medicine, November 1, 2005; 230(10): 699 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Nony, S. B. Kennett, W. C. Glasgow, K. Olden, and J. D. Roberts 15(S)-Lipoxygenase-2 Mediates Arachidonic Acid-stimulated Adhesion of Human Breast Carcinoma Cells through the Activation of TAK1, MKK6, and p38 MAPK J. Biol. Chem., September 9, 2005; 280(36): 31413 - 31419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Kim, S. J. Baek, F. G. Bottone Jr., T. Sali, and T. E. Eling Overexpression of 15-Lipoxygenase-1 Induces Growth Arrest through Phosphorylation of p53 in Human Colorectal Cancer Cells Mol. Cancer Res., September 1, 2005; 3(9): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Yu, P. J. Moos, P. Cassidy, M. Wade, and F. A. Fitzpatrick Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase: MODULATION OF SELENOPROTEINS BY LIPOXYGENASE ENZYMES J. Biol. Chem., July 2, 2004; 279(27): 28028 - 28035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Shappell, S. J. Olson, S. E. Hannah, S. Manning, R. L. Roberts, N. Masumori, M. Jisaka, W. E. Boeglin, V. Vader, D. S. Dave, et al. Elevated Expression of 12/15-Lipoxygenase and Cyclooxygenase-2 in a Transgenic Mouse Model of Prostate Carcinoma Cancer Res., May 1, 2003; 63(9): 2256 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chanez, C. Bonnans, C. Chavis, and I. Vachier 15-Lipoxygenase: A Janus Enzyme? Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 655 - 658. [Full Text] [PDF]
|
|
|
|
|
|
L. C. Hsi, L. C. Wilson, and T. E. Eling Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate. ALTERATION IN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma J. Biol. Chem., October 18, 2002; 277(43): 40549 - 40556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tang, B. Bhatia, C. J. Maldonado, P. Yang, R. A. Newman, J. Liu, D. Chandra, J. Traag, R. D. Klein, S. M. Fischer, et al. Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells J. Biol. Chem., May 3, 2002; 277(18): 16189 - 16201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Bottone Jr., S. J. Baek, J. B. Nixon, and T. E. Eling Diallyl Disulfide (DADS) Induces the Antitumorigenic NSAID-Activated Gene (NAG-1) by a p53-Dependent Mechanism in Human Colorectal HCT 116 Cells J. Nutr., April 1, 2002; 132(4): 773 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Hsi, L. Wilson, J. Nixon, and T. E. Eling 15-Lipoxygenase-1 Metabolites Down-regulate Peroxisome Proliferator-activated Receptor gamma via the MAPK Signaling Pathway J. Biol. Chem., September 7, 2001; 276(37): 34545 - 34552. [Abstract] [Full Text] [PDF]
|
|